Hearing dogs for people with severe and profound hearing loss: a wait-list design randomised controlled trial investigating their effectiveness and cost-effectiveness

被引:4
|
作者
Stuttard, Lucy [1 ]
Boyle, Philip [1 ]
Fairhurst, Caroline [2 ]
Hewitt, Catherine [2 ]
Longo, Francesco [3 ]
Walker, Simon [3 ]
Weatherly, Helen [3 ]
Mayhew, Emese [1 ]
Beresford, Bryony [1 ]
机构
[1] Univ York, Dept Social Policy & Social Work, Social Policy Res Unit, Church Lane Bldg,York Sci Pk, Heslington YO10 5DF, England
[2] Univ York, York Trials Unit, York YO10 5DD, N Yorkshire, England
[3] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England
关键词
GENERALIZED ANXIETY DISORDER; SERVICE DOGS; ADULTS; IMPAIRMENT; SCALE; DISABILITIES; WORK;
D O I
10.1186/s13063-021-05607-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Hearing loss increases the risk of poor outcomes across a range of life domains. Where hearing loss is severe or profound, audiological interventions and rehabilitation have limited impact. Hearing dogs offer an alternative, or additional, intervention. They live permanently with recipients, providing sound support and companionship. Methods: A single-centre, randomised controlled trial (RCT) evaluated the impacts of a hearing dog on mental well-being, anxiety, depression, problems associated with hearing loss (responding to sounds, fearfulness/social isolation), and perceived dependency on others. Participants were applicants to the UK charity `Hearing Dogs for Deaf People'. Eligibility criteria were as follows: first-time applicant; applying for a hearing dog (as opposed to other support provided by the charity). Participants were randomised 1:1 to the following: receive a hearing dog sooner than usual [HD], or within the usual application timeframe (wait-list [WL] comparator). The primary outcome was mental well-being (Short Warwick-Edinburgh Mental Well-Being Scale) 6 months (T1) after HD received a hearing dog. The cost-effectiveness analysis took a health and social care perspective. Results: In total, 165 participants were randomised (HD n = 83, WL n = 82). A total of 112 (67.9%) were included in the primary analysis (HD n = 55, WL n = 57). At T1, mental well-being was significantly higher in the HD arm (adjusted mean difference 2.53, 95% CI 1.27 to 3.79, p < 0.001). Significant improvements in anxiety, depression, functioning, fearfulness/social isolation, and perceived dependency, favouring the HD arm, were also observed. On average, HD participants had used fewer statutory health and social care resources. In a scenario whereby costs of provision were borne by the public sector, hearing dogs do not appear to be value for money. If the public sector made a partial contribution, it is possible that hearing dogs would be cost-effective from a public sector perspective. Conclusions: Hearing dogs appear to benefit recipients across a number of life domains, at least in the short term. Within the current funding model (costs entirely borne by the charity), hearing dogs are cost-effective from the public sector perspective. Whilst it would not be cost-effective to fully fund the provision of hearing dogs by the public sector, a partial contribution could be explored.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Cost-effectiveness of aftercare services for people with severe mental disorders: an analysis parallel to a randomised controlled clinical trial in Iran
    Moradi-Lakeh, Maziar
    Yaghoubi, Mohsen
    Hajebi, Ahmad
    Malakouti, Seyed Kazem
    Vasfi, Mohamad Ghadiri
    HEALTH & SOCIAL CARE IN THE COMMUNITY, 2017, 25 (03) : 1151 - 1159
  • [32] Effectiveness and cost-effectiveness of web-based treatment for phobic outpatients on a waiting list for psychotherapy: protocol of a randomised controlled trial
    Robin N Kok
    Annemieke van Straten
    Aartjan Beekman
    Judith Bosmans
    Manja de Neef
    Pim Cuijpers
    BMC Psychiatry, 12
  • [33] Effectiveness and cost-effectiveness of web-based treatment for phobic outpatients on a waiting list for psychotherapy: protocol of a randomised controlled trial
    Kok, Robin N.
    van Straten, Annemieke
    Beekman, Aartjan
    Bosmans, Judith
    de Neef, Manja
    Cuijpers, Pim
    BMC PSYCHIATRY, 2012, 12
  • [34] Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial
    Soares, Marta O.
    Welton, Nicky J.
    Harrison, David A.
    Peura, Piia
    Shankar-Hari, Manu
    Harvey, Sheila E.
    Madan, Jason
    Ades, Anthony E.
    Rowan, Kathryn M.
    Palmer, Stephen J.
    CRITICAL CARE, 2014, 18 (06)
  • [35] Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial
    Marta O Soares
    Nicky J Welton
    David A Harrison
    Piia Peura
    Manu Shankar-Hari
    Sheila E Harvey
    Jason Madan
    Anthony E Ades
    Kathryn M Rowan
    Stephen J Palmer
    Critical Care, 18
  • [36] Cost-effectiveness of child caries management: a randomised controlled trial (FiCTION trial)
    Tara Homer
    Anne Maguire
    Gail V. A. Douglas
    Nicola P. Innes
    Jan E. Clarkson
    Nina Wilson
    Vicky Ryan
    Elaine McColl
    Mark Robertson
    Luke Vale
    BMC Oral Health, 20
  • [37] Cost-effectiveness of child caries management: a randomised controlled trial (FiCTION trial)
    Homer, Tara
    Maguire, Anne
    Douglas, Gail V. A.
    Innes, Nicola P.
    Clarkson, Jan E.
    Wilson, Nina
    Ryan, Vicky
    McColl, Elaine
    Robertson, Mark
    Vale, Luke
    BMC ORAL HEALTH, 2020, 20 (01)
  • [38] Effectiveness of Gyejibongnyeong-Hwan for shoulder pain: study protocol for a randomised, wait-list controlled pilot trial (vol 21, 193, 2020)
    Jang, Soobin
    Sung, Hyun Kyung
    Ko, Mi Mi
    Shin, Seon Mi
    Go, Ho-Yeon
    Jung, Jeeyoun
    TRIALS, 2020, 21 (01)
  • [39] Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial
    Romeo, Renee
    Knapp, Martin
    Hellier, Jennifer
    Dewey, Michael
    Ballard, Clive
    Baldwin, Robert
    Bentham, Peter
    Burns, Alistair
    Fox, Chris
    Holmes, Clive
    Katona, Cornelius
    Lawton, Claire
    Lindesay, James
    Livingston, Gill
    McCrae, Niall
    Moniz-Cook, Esme
    Murray, Joanna
    Nurock, Shirley
    O'Brien, John
    Poppe, Michaela
    Thomas, Alan
    Walwyn, Rebecca
    Wilson, Kenneth
    Banerjee, Sube
    BRITISH JOURNAL OF PSYCHIATRY, 2013, 202 (02) : 121 - 128
  • [40] Cost-effectiveness of a lifestyle intervention for hypertension: An open randomised controlled trial
    Martikainen, J. A.
    Kastarinen, M.
    Puska, P.
    Nissinen, A.
    VALUE IN HEALTH, 2006, 9 (06) : A340 - A340